Neurobiological studies of fatigue

Progress in Neurobiology

Volumn 99, Issue 2, 2012, Pages 93-105

  Harrington, Mary E ^a  

^a SMITH COLLEGE   (United States)

Author keywords

Animal model; Circadian; Cytokine; Fatigue; Suprachiasmatic

Indexed keywords

ALPHA INTERFERON; BRAIN DERIVED NEUROTROPHIC FACTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; OREXIN A; PROTEIN BMAL1; PSYCHOSTIMULANT AGENT; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRANSCRIPTION FACTOR CLOCK; TUMOR NECROSIS FACTOR ALPHA;

AEROBIC EXERCISE; AFRICAN TRYPANOSOMIASIS; AROUSAL; BASAL GANGLION; CANCER FATIGUE; CHRONIC FATIGUE SYNDROME; CIRCADIAN RHYTHM; COGNITIVE THERAPY; CRYPTOSPORIDIOSIS; DAYTIME SOMNOLENCE; DENTATE GYRUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSTHYMIA; FATIGUE; HELPLESSNESS; HIPPOCAMPUS; HUMAN; INNATE IMMUNITY; LOCOMOTION; MEDIAL PREOPTIC AREA; MEMORY CONSOLIDATION; MULTIPLE SCLEROSIS; NARCOLEPSY; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NICK END LABELING; NONHUMAN; NONREM SLEEP; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAXATION TRAINING; REVIEW; REWARD; RUNNING; SELF REPORT; SLEEP DISORDER; SLEEP QUALITY; SLEEP WAKING CYCLE; SOCIAL INTERACTION; SOCIAL STATUS; SUPRACHIASMATIC NUCLEUS; TOXOPLASMOSIS; VENTRAL TEGMENTUM; VIRUS INFECTION; VOLUNTARY WHEEL RUNNING; WAKEFULNESS;

ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BRAIN; DISEASE MODELS, ANIMAL; FATIGUE; FATIGUE SYNDROME, CHRONIC; HUMANS; NEUROBIOLOGY;

EID: 84867898106     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2012.07.004     Document Type: Review

References (164)

1. Abraham J., Johnson R.W. Central inhibition of interleukin-1beta ameliorates sickness behavior in aged mice. Brain Behav. Immun. 2009, 23:396-401.
2. Ancoli-Israel S., Rissling M., Neikrug A., Trofimenko V., Natarajan L., Parker B.A., Lawton S., Desan P., Liu L. Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer. Support. Care Cancer 2012, 20:1211-1219.
3. Anisman H., Gibb J., Hayley S. Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology (Berl.) 2008, 199:231-244.
4. Asai M., Yoshinobu Y., Kaneko S., Mori A., Nikaido T., Moriya T., Akiyama M., Shibata S. Circadian profile of Per gene mRNA expression in the suprachiasmatic nucleus, paraventricular nucleus, and pineal body of aged rats. J. Neurosci. Res. 2001, 66:1133-1139.
5. Aston-Jones G., Smith R.J., Sartor G.C., Moorman D.E., Massi L., Tahsili-Fahadan P., Richardson K.A. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res. 2010, 1314:74-90.
6. Avlund K., Pedersen A.N., Schroll M. Functional decline from age 80 to 85: influence of preceding changes in tiredness in daily activities. Psychosom. Med. 2003, 65:771-777.
7. Avlund K., Vass M., Hendriksen C. Onset of mobility disability among community-dwelling old men and women. The role of tiredness in daily activities. Age Ageing 2003, 32:579-584.
8. Baba K., Ono D., Honma S., Honma K. A TTX-sensitive local circuit is involved in the expression of PK2 and BDNF circadian rhythms in the mouse suprachiasmatic nucleus. Eur. J. Neurosci. 2008, 27:909-916.
9. Bake S., Friedman J.A., Sohrabji F. Reproductive age-related changes in the blood brain barrier: expression of IgG and tight junction proteins. Microvasc. Res. 2009, 78:413-424.
10. Bake S., Sohrabji F. 17beta-estradiol differentially regulates blood-brain barrier permeability in young and aging female rats. Endocrinology 2004, 145:5471-5475.
11. Bandeen-Roche K., Walston J.D., Huang Y., Semba R.D., Ferrucci L. Measuring systemic inflammatory regulation in older adults: evidence and utility. Rejuvenation Res. 2009, 12:403-410.
12. Barsevick A.M., Cleeland C.S., Manning D.C., O'Mara A.M., Reeve B.B., Scott J.A., Sloan J.A. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J. Pain Symptom Manage. 2010, 39:1086-1099. ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes).
13. Bautmans I., Njemini R., De Backer J., De Waele E., Mets T. Surgery-induced inflammation in relation to age, muscle endurance, and self-perceived fatigue. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65:266-273.
14. Beery A.K., Zucker I. Sex bias in neuroscience and biomedical research. Neurosci. Biobehav. Rev. 2011, 35:565-572.
15. Benca R., Duncan M.J., Frank E., McClung C., Nelson R.J., Vicentic A. Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges. Brain Res. Rev. 2009, 62:57-70.
16. Bentivoglio M., Deng X.H., Nygård M., Sadki A., Kristensson K. The aging suprachiasmatic nucleus and cytokines: functional, molecular, and cellular changes in rodents. Chronobiol Int. 2006, 23:437-449.
17. Bentivoglio M., Mariotti R., Bertini G. Neuroinflammation and brain infections: historical context and current perspectives. Brain Res. Rev. 2011, 66:152-173.
18. Beynon A.L., Coogan A.N. Diurnal, age, and immune regulation of interleukin-1beta and interleukin-1 type 1 receptor in the mouse suprachiasmatic nucleus. Chronobiol. Int. 2010, 27:1546-1563.
19. Bliwise D.L. Sleep in normal aging and dementia. Sleep 1993, 16:40-81.
20. Bower J.E., Ganz P.A., Tao M.L., Hu W., Belin T.R., Sepah S., Cole S., Aziz N. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin. Cancer Res. 2009, 15:5534-5540.
21. Bronikowski A.M., Carter P.A., Swallow J.G., Girard I.A., Rhodes J.S., Garland T. Open-field behavior of house mice selectively bred for high voluntary wheel-running. Behav. Genet. 2001, 31:309-316.
22. Calabrese M., Rinaldi F., Grossi P., Mattisi I., Bernardi V., Favaretto A., Perini P., Gallo P. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis. Mult. Scler. 2010, 16:1220-1228.
23. Cantor F. Central and peripheral fatigue: exemplified by multiple sclerosis and myasthenia gravis. PM R 2010, 2:399-405.
24. Cantor J.B., Ashman T., Gordon W., Ginsberg A., Engmann C., Egan M., Spielman L., Dijkers M., Flanagan S. Fatigue after traumatic brain injury and its impact on participation and quality of life. J. Head Trauma Rehabil. 2008, 23:41-51.
25. Capuron L., Miller A.H. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther. 2011, 130:226-238.
26. Cavadini G., Petrzilka S., Kohler P., Jud C., Tobler I., Birchler T., Fontana A. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12843-12848.
27. Chao C.C., DeLaHunt M., Hu S., Close K., Peterson P.K. Immunologically mediated fatigue: a murine model. Clin. Immunol. Immunopathol. 1992, 64:161-165.
28. Chaudhuri A., Behan P.O. Fatigue and basal ganglia. J. Neurol. Sci. 2000, 179:34-42.
29. Chen R., Moriya J., Yamakawa J., Takahashi T., Li Q., Morimoto S., Iwai K., Sumino H., Yamaguchi N., Kanda T. Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41). Neurochem. Res. 2008, 33:1759-1767.
30. Chou T.C., Scammell T.E., Gooley J.J., Gaus S.E., Saper C.B., Lu J. Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J. Neurosci. 2003, 23:10691-10702.
31. Christley Y., Duffy T., Martin C.R. A review of the definitional criteria for chronic fatigue syndrome. J. Eval. Clin. Pract. 2012, 18:25-31.
32. Clark M.R., Katon W., Russo J., Kith P., Sintay M., Buchwald D. Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study. Am. J. Med. 1995, 98:187-195.
33. Cohen R.A., Albers H.E. Disruption of human circadian and cognitive regulation following a discrete hypothalamic lesion: a case study. Neurology 1991, 41:726-729.
34. Collado-Hidalgo A., Bower J.E., Ganz P.A., Irwin M.R., Cole S.W. Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings. Brain Behav. Immun. 2008, 22:1197-1200.
35. Colwell C.S. Linking neural activity and molecular oscillations in the SCN. Nat. Rev. Neurosci. 2011, 12:553-569.
36. Coogan A.N., Wyse C.A. Neuroimmunology of the circadian clock. Brain Res. 2008, 1232:104-112.
37. Cope H. Fatigue: a non-specific complaint?. Int. Rev. Psychiatry 1992, 4:273-280.
38. Corona A.W., Fenn A.M., Godbout J.P. Cognitive and behavioral consequences of impaired immunoregulation in aging. J. Neuroimmune Pharmacol. 2012, 7:7-23.
39. Cunningham C., Campion S., Teeling J., Felton L., Perry V.H. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav. Immun. 2007, 21:490-502.
40. Dantzer R. Cytokine, sickness behavior, and depression. Immunol. Allergy Clin. North. Am. 2009, 29:247-264.
41. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
42. De Chiara V., Errico F., Musella A., Rossi S., Mataluni G., Sacchetti L., Siracusano A., Castelli M., Cavasinni F., Bernardi G., Usiello A., Centonze D. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology 2010, 35:374-387.
43. Deacon R.M. Burrowing: a sensitive behavioural assay, tested in five species of laboratory rodents. Behav. Brain Res. 2009, 200:128-133.
44. DeFries J.C., Wilson J.R., McClearn G.E. Open-field behavior in mice: selection response and situational generality. Behav. Genet. 1970, 1:195-211.
45. DeLuca J., Genova H.M., Capili E.J., Wylie G.R. Functional neuroimaging of fatigue. Phys. Med. Rehabil. Clin. N. Am. 2009, 20:325-337.
46. Deng X.H., Bertini G., Palomba M., Xu Y.Z., Bonaconsa M., Nygard M., Bentivoglio M. Glial transcripts and immune-challenged glia in the suprachiasmatic nucleus of young and aged mice. Chronobiol. Int. 2010, 27:742-767.
47. Droogleever Fortuyn H.A., Fronczek R., Smitshoek M., Overeem S., Lappenschaar M., Kalkman J., Renier W., Buitelaar J., Lammers G.J., Bleijenberg G. Severe fatigue in narcolepsy with cataplexy. J. Sleep Res. 2012, 21:163-169.
48. Dubreucq S., Koehl M., Abrous D.N., Marsicano G., Chaouloff F. CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis. Exp. Neurol. 2010, 224:106-113.
49. Edgar D.M., Dement W.C., Fuller C.A. Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation. J. Neurosci. 1993, 13:1065-1079.
50. Elbers, R.G., Rietberg, M.B., van Wegen, E.E., Verhoef, J., Kramer, S.F., Terwee, C.B., Kwakkel, G., 2011. Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties. Qual Life Res. PMID: pmid:22012025.
51. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., Guralnik J.M., Longo D.L. The origins of age-related proinflammatory state. Blood 2005, 105:2294-2299.
52. Fil D., Borysiewicz E., Konat G.W. A broad upregulation of cerebral chemokine genes by peripherally-generated inflammatory mediators. Metab. Brain Dis. 2011, 26:49-59.
53. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., Seeman T., Tracy R., Kop W.J., Burke G., McBurnie M.A. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56:M146-M156. Cardiovascular Health Study Collaborative Research Group.
54. Fuller P.M., Gooley J.J., Saper C.B. Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback. J. Biol. Rhythms 2006, 21:482-493.
55. Garcia Samartino C., Delpino M.V., Pott Godoy C., Di Genaro M.S., Pasquevich K.A., Zwerdling A., Barrionuevo P., Mathieu P., Cassataro J., Pitossi F., Giambartolomei G.H. Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis. Am. J. Pathol. 2010, 176:1323-1338.
56. Gaykema R.P., Goehler L.E. Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: brain substrates for fatigue?. Brain Behav. Immun. 2011, 25:443-460.
57. Gerber L.H. Some unresolved issues for the study of fatigue: the way forward. PM R. 2010, 2:466-468.
58. Godbout J.P., Moreau M., Lestage J., Chen J., Sparkman N.L., O'Connor J., Castanon N., Kelley K.W., Dantzer R., Johnson R.W. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology 2008, 33:2341-2351.
59. Goetzl E.J., Huang M.C., Kon J., Patel K., Schwartz J.B., Fast K., Ferrucci L., Madara K., Taub D.D., Longo D.L. Gender specificity of altered human immune cytokine profiles in aging. FASEB J. 2010, 24:3580-3589.
60. Hannibal J., Hsiung H.M., Fahrenkrug J. Temporal phasing of locomotor activity, heart rate rhythmicity, and core body temperature is disrupted in VIP receptor 2-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R519-R530.
61. Harden L.M., du Plessis I., Roth J., Loram L.C., Poole S., Laburn H.P. Differences in the relative involvement of peripherally released interleukin (IL)-6, brain IL-1beta and prostanoids in mediating lipopolysaccharide-induced fever and sickness behavior. Psychoneuroendocrinology 2011, 36:608-622.
62. Hardy S.E., Studenski S.A. Fatigue predicts mortality in older adults. J. Am. Geriatr. Soc. 2008, 56:1910-1914.
63. Hjollund N.H., Andersen J.H., Bech P. Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual. Life Outcomes 2007, 5:12.
64. Horneber M., Fischer I., Dimeo F., Rüffer J.U., Weis J. Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Dtsch. Arztebl. Int. 2012, 109:161-171.
65. Hu K., Scheer F.A., Ivanov P.C., Buijs R.M., Shea S.A. The suprachiasmatic nucleus functions beyond circadian rhythm generation. Neuroscience 2007, 149:508-517.
66. Huitron-Resendiz S., Marcondes M.C., Flynn C.T., Lanigan C.M., Fox H.S. Effects of simian immunodeficiency virus on the circadian rhythms of body temperature and gross locomotor activity. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15138-15143.
67. Imeri L., Ceccarelli P., Mariotti M., Manfridi A., Opp M.R., Mancia M. Sleep, but not febrile responses of Fisher 344 rats to immune challenge are affected by aging. Brain Behav. Immun. 2004, 18:399-404.
68. Imeri L., Opp M.R. How (and why) the immune system makes us sleep. Nat. Rev. Neurosci. 2009, 10:199-210.
69. Jean-Pierre P., Morrow G.R., Roscoe J.A., Heckler C., Mohile S., Janelsins M., Peppone L., Hemstad A., Esparaz B.T., Hopkins J.O. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 2010, 116:3513-3520.
70. Jobst E.E., Robinson D.W., Allen C.N. Potential pathways for intercellular communication within the calbindin subnucleus of the hamster suprachiasmatic nucleus. Neuroscience 2004, 123:87-99.
71. Katafuchi T., Kondo T., Take S., Yoshimura M. Brain cytokines and the 5-HT system during poly I:C-induced fatigue. Ann. N. Y. Acad. Sci. 2006, 1088:230-237.
72. Katafuchi T., Kondo T., Take S., Yoshimura M. Enhanced expression of brain interferon-alpha and serotonin transporter in immunologically induced fatigue in rats. Eur. J. Neurosci. 2005, 22:2817-2826.
73. Katafuchi T., Kondo T., Yasaka T., Kubo K., Take S., Yoshimura M. Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-alpha mRNA in rats: a model for immunologically induced fatigue. Neuroscience 2003, 120:837-845.
74. Kirsh K.L., Passik S., Holtsclaw E., Donaghy K., Theobald D. I get tired for no reason: a single item screening for cancer-related fatigue. J. Pain Symptom Manage. 2001, 22:931-937.
75. Knab A.M., Lightfoot J.T. Does the difference between physically active and couch potato lie in the dopamine system?. Int. J. Biol. Sci. 2010, 6:133-150.
76. Knoop H., van Kessel K., Moss-Morris R. Which cognitions and behaviours mediate the positive effect of cognitive behavioural therapy on fatigue in patients with multiple sclerosis?. Psychol. Med. 2012, 42:205-213.
77. Ko C.H., Takahashi J.S. Molecular components of the mammalian circadian clock. Hum.Mol.Genet. 2006, 15(Spec no. 2):R271-R277.
78. Kohman R.A., Rodriguez-Zas S.L., Southey B.R., Kelley K.W., Dantzer R., Rhodes J.S. Voluntary wheel running reverses age-induced changes in hippocampal gene expression. PLoS One 2011, 6:e22654.
79. Kolker D.E., Fukuyama H., Huang D.S., Takahashi J.S., Horton T.H., Turek F.W. Aging alters circadian and light-induced expression of clock genes in golden hamsters. J. Biol. Rhythms 2003, 18:159-169.
80. Kondo S., Kohsaka S., Okabe S. Long-term changes of spine dynamics and microglia after transient peripheral immune response triggered by LPS in vivo. Mol. Brain 2011, 4:27.
81. Konsman J.P., Veeneman J., Combe C., Poole S., Luheshi G.N., Dantzer R. Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur. J. Neurosci. 2008, 28:2499-2510.
82. Kos D., Kerckhofs E., Nagels G., D'hooghe M.B., Ilsbroukx S. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil. Neural Repair 2008, 22:91-100.
83. Koyanagi S., Ohdo S. Alteration of intrinsic biological rhythms during interferon treatment and its possible mechanism. Mol. Pharmacol. 2002, 62:1393-1399.
84. Kramer A., Yang F.C., Snodgrass P., Li X., Scammell T.E., Davis F.C., Weitz C.J. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science. 2001, 294:2511-2515.
85. Kraves S., Weitz C.J. A role for cardiotrophin-like cytokine in the circadian control of mammalian locomotor activity. Nat. Neurosci. 2006, 9:212-219.
86. Kristensson K., Nygard M., Bertini G., Bentivoglio M. African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions. Prog. Neurobiol. 2010, 91:152-171.
87. Kudo T., Loh D.H., Truong D., Wu Y., Colwell C.S. Circadian dysfunction in a mouse model of Parkinson's disease. Exp. Neurol. 2011, 232:66-75.
88. Kudo T., Schroeder A., Loh D.H., Kuljis D., Jordan M.C., Roos K.P., Colwell C.S. Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease. Exp. Neurol. 2011, 228:80-90.
89. Kwak Y., Lundkvist G.B., Brask J., Davidson A., Menaker M., Kristensson K., Block G.D. Interferon-gamma alters electrical activity and clock gene expression in suprachiasmatic nucleus neurons. J. Biol. Rhythms 2008, 23:150-159.
90. Li J.D., Hu W.P., Boehmer L., Cheng M.Y., Lee A.G., Jilek A., Siegel J.M., Zhou Q.Y. Attenuated circadian rhythms in mice lacking the prokineticin 2 gene. J. Neurosci. 2006, 26:11615-11623.
91. Li X., Sankrithi N., Davis F.C. Transforming growth factor-alpha is expressed in astrocytes of the suprachiasmatic nucleus in hamster: role of glial cells in circadian clocks. Neuroreport 2002, 13:2143-2147.
92. Liu, L., Mills, P.J., Rissling, M., Fiorentino, L., Natarajan, L., Dimsdale, J.E., Sadler, G.R., Parker, B.A., Ancoli-Israel, S., 2012. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun. Mar 2. [Epub ahead of print] PubMed PMID: 22406004.
93. Liu L., Rissling M., Natarajan L., Fiorentino L., Mills P.J., Dimsdale J.E., Sadler G.R., Parker B.A., Ancoli-Israel S. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep 2012, 35:237-245.
94. Lu J., Greco M.A., Shiromani P., Saper C.B. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J. Neurosci. 2000, 20:3830-3842.
95. Lundkvist G.B., Christenson J., ElTayeb R.A., Peng Z.C., Grillner P., Mhlanga J., Bentivoglio M., Kristensson K. Altered neuronal activity rhythm and glutamate receptor expression in the suprachiasmatic nuclei of Trypanosoma brucei-infected rats. J. Neuropathol. Exp. Neurol. 1998, 57:21-29.
96. Lundkvist G.B., Hill R.H., Kristensson K. Disruption of circadian rhythms in synaptic activity of the suprachiasmatic nuclei by African trypanosomes and cytokines. Neurobiol. Dis. 2002, 11:20-27.
97. Lundkvist G.B., Robertson B., Mhlanga J.D., Rottenberg M.E., Kristensson K. Expression of an oscillating interferon-gamma receptor in the suprachiasmatic nuclei. Neuroreport 1998, 9:1059-1063.
98. Lundkvist G.B., Sellix M.T., Nygard M., Davis E., Straume M., Kristensson K., Block G.D. Clock gene expression during chronic inflammation induced by infection with Trypanosoma brucei brucei in rats. J. Biol. Rhythms 2010, 25:92-102.
99. Luo A.H., Aston-Jones G. Circuit projection from suprachiasmatic nucleus to ventral tegmental area: a novel circadian output pathway. Eur. J. Neurosci. 2009, 29:748-760.
100. Ma Y.J., Berg-von der Emde K., Moholt-Siebert M., Hill D.F., Ojeda S.R. Region-specific regulation of transforming growth factor alpha (TGF alpha) gene expression in astrocytes of the neuroendocrine brain. J. Neurosci. 1994, 14:5644-5651.
101. Marpegán L., Bekinschtein T.A., Costas M.A., Golombek D.A. Circadian responses to endotoxin treatment in mice. J Neuroimmunol. 2005, 160:102-109.
102. Mathes W.F., Nehrenberg D.L., Gordon R., Hua K., Garland T., Pomp D. Dopaminergic dysregulation in mice selectively bred for excessive exercise or obesity. Behav. Brain Res. 2010, 210:155-163.
103. McNeely M.L., Campbell K.L., Rowe B.H., Klassen T.P., Mackey J.R., Courneya K.S. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 2006, 175:34-41.
104. Mistlberger R.E. Circadian regulation of sleep in mammals: role of the suprachiasmatic nucleus. Brain Res. Brain Res. Rev. 2005, 49:429-454.
105. Monk T.H., Buysse D.J., Reynolds C.F., Kupfer D.J., Houck P.R. Circadian temperature rhythms of older people. Exp. Gerontol. 1995, 30:455-474.
106. Moorman D.E., Aston-Jones G. Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences. J Neurosci. 2010, 30:15585-15599.
107. Moreh E., Jacobs J.M., Stessman J. Fatigue, function, and mortality in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65:887-895.
108. Moriya J., Chen R., Yamakawa J., Sasaki K., Ishigaki Y., Takahashi T. Resveratrol improves hippocampal atrophy in chronic fatigue mice by enhancing neurogenesis and inhibiting apoptosis of granular cells. Biol. Pharm. Bull. 2011, 34:354-359.
109. Morley J.E., Baumgartner R.N. Cytokine-related aging process. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:M924-M929.
110. Morrow G.R., Shelke A.R., Roscoe J.A., Hickok J.T., Mustian K. Management of cancer-related fatigue. Cancer Invest. 2005, 23:229-239.
111. Munch M., Knoblauch V., Blatter K., Schroder C., Schnitzler C., Krauchi K., Wirz-Justice A., Cajochen C. Age-related attenuation of the evening circadian arousal signal in humans. Neurobiol. Aging 2005, 26:1307-1319.
112. Nakamura T.J., Nakamura W., Yamazaki S., Kudo T., Cutler T., Colwell C.S., Block G.D. Age-related decline in circadian output. J. Neurosci. 2011, 31:10201-10205.
113. Nava F., Carta G., Haynes L.W. Lipopolysaccharide increases arginine-vasopressin release from rat suprachiasmatic nucleus slice cultures. Neurosci. Lett. 2000, 288:228-230.
114. Nijhof S.L., Bleijenberg G., Uiterwaal C.S., Kimpen J.L., van de Putte E.M. Effectiveness of internet-based cognitive behavioural treatment for adolescentswith chronic fatigue syndrome (FITNET): a randomised controlled trial. Lancet 2012, 379:1412-1418.
115. Norheim K.B., Harboe E., Gøransson L.G., Omdal R. Interleukin-1 inhibition andfatigue in primary Sjögren's syndrome--a double blind, randomised clinical trial. PLoS One 2012, 7:e30123.
116. Nygard M., Lundkvist G.B., Hill R.H., Kristensson K. Rapid nitric oxide-dependent effects of tumor necrosis factor-alpha on suprachiasmatic nuclei neuronal activity. Neuroreport 2009, 20:213-217.
117. Ohdo S., Koyanagi S., Suyama H., Higuchi S., Aramaki H. Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat. Med. 2001, 7:356-360.
118. Okada K., Yano M., Doki Y., Azama T., Iwanaga H., Miki H., Nakayama M., Miyata H., Takiguchi S., Fujiwara Y., Yasuda T., Ishida N., Monden M. Injection of LPS causes transient suppression of biological clock genes in rats. J. Surg. Res. 2008, 145:5-12.
119. Olivadoti M.D., Weinberg J.B., Toth L.A., Opp M.R. Sleep and fatigue in mice infected with murine gammaherpesvirus 68. Brain Behav. Immun. 2011, 25:696-705.
120. Ottenweller J.E., Natelson B.H., Gause W.C., Carroll K.K., Beldowicz D., Zhou X.D., LaManca J.J. Mouse running activity is lowered by Brucella abortus treatment: a potential model to study chronic fatigue. Physiol. Behav. 1998, 63:795-801.
121. Patro I.K., Amit Shrivastava M., Bhumika S., Patro N. Poly I:C induced microglial activation impairs motor activity in adult rats. Indian J. Exp. Biol. 2010, 48:104-109.
122. Pavese N., Metta V., Bose S.K., Chaudhuri K.R., Brooks D.J. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain 2010, 133:3434-3443.
123. Perry V.H. Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol. 2010, 120:277-286.
124. Power A., Hughes A.T., Samuels R.E., Piggins H.D. Rhythm-promoting actions of exercise in mice with deficient neuropeptide signaling. J. Biol. Rhythms 2010, 25:235-246.
125. Price J.R., Mitchell E., Tidy E., Hunot V. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database Syst. Rev. 2008, 3:CD001027.
126. Prosser H.M., Bradley A., Chesham J.E., Ebling F.J., Hastings M.H., Maywood E.S. Prokineticin receptor 2 (Prokr2) is essential for the regulation of circadian behavior by the suprachiasmatic nuclei. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:648-653.
127. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
128. Qiu M.H., Vetrivelan R., Fuller P.M., Lu J. Basal ganglia control of sleep-wake behavior and cortical activation. Eur. J. Neurosci. 2010, 31:499-507.
129. Rabkin J.G., McElhiney M.C., Rabkin R. Modafinil and armodafinil treatment for fatigue for HIV-positive patients with and without chronic hepatitis C. Int. J. STD AIDS 2011, 22:95-101.
130. Ray M., Rogers L.Q., Trammell R.A., Toth L.A. Fatigue and sleep during cancer and chemotherapy: translational rodent models. Comp. Med 2008, 58:234-245.
131. Ray M.A., Trammell R.A., Verhulst S., Ran S., Toth L.A. Development of a mouse model for assessing fatigue during chemotherapy. Comp. Med. 2011, 61:119-130.
132. Rhodes J.S., Gammie S.C., Garland T. Neurobiology of mice selected for high voluntary wheel-running activity. Integr. Comp. Biol. 2005, 45:438-455.
133. Rhodes J.S., Garland T., Gammie S.C. Patterns of brain activity associated with variation in voluntary wheel-running behavior. Behav. Neurosci. 2003, 117:1243-1256.
134. Roberts M.D., Gilpin L., Parker K.E., Childs T.E., Will M.J., Booth F.W. Dopamine D1 receptor modulation in nucleus accumbens lowers voluntary wheel running in rats bred to run high distances. Physiol. Behav. 2011, 105:661-668.
135. Rosenwasser A.M. Functional neuroanatomy of sleep and circadian rhythms. Brain Res. Rev. 2009, 61:281-306.
136. Sadki A., Bentivoglio M., Kristensson K., Nygard M. Suppressors, receptors and effects of cytokines on the aging mouse biological clock. Neurobiol. Aging 2007, 28:296-305.
137. Saper C.B., Fuller P.M., Pedersen N.P., Lu J., Scammell T.E. Sleep state switching. Neuron 2010, 68:1023-1042.
138. Sasu B.J., Cooke K.S., Arvedson T.L., Plewa C., Ellison A.R., Sheng J., Winters A., Juan T., Li H., Begley C.G., Molineux G. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 2010, 115:3616-3624.
139. Satinoff E., Li H., Tcheng T.K., Liu C., McArthur A.J., Medanic M., Gillette M.U. Do the suprachiasmatic nuclei oscillate in old rats as they do in young ones?. Am. J. Physiol. 1993, 265:R1216-R1222.
140. Schubert C., Hong S., Natarajan L., Mills P.J., Dimsdale J.E. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav. Immun. 2007, 21:413-427.
141. Sherwin C.M. Voluntary wheel running: a review and novel interpretation. Anim. Behav. 1998, 56:11-27.
142. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002, 22:3251-3261.
143. Smith A.K., Fang H., Whistler T., Unger E.R., Rajeevan M.S. Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome. Neuropsychobiology 2011, 64:183-194.
144. Snodgrass-Belt P., Gilbert J.L., Davis F.C. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters. Brain Res. 2005, 1038:171-182.
145. Tanaka M., Nakamura F., Mizokawa S., Matsumura A., Nozaki S., Watanabe Y. Establishment and assessment of a rat model of fatigue. Neurosci. Lett. 2003, 352:159-162.
146. Tang W.K., Chen Y.K., Mok V., Chu W., Ungvari G.S., Ahuja A.T., Wong K.S. Acute basal ganglia infarcts in poststroke fatigue: an MRI study. J. Neurol. 2010, 257:178-182.
147. Taraborrelli C., Palchykova S., Tobler I., Gast H., Birchler T., Fontana A. TNFR1 is essential for CD40, but not for lipopolysaccharide-induced sickness behavior and clock gene dysregulation. Brain Behav. Immun. 2011, 25:434-442.
148. Tarr A.J., McLinden K.A., Kranjac D., Kohman R.A., Amaral W., Boehm G.W. The effects of age on lipopolysaccharide-induced cognitive deficits and interleukin-1beta expression. Behav. Brain Res. 2011, 217:481-485.
149. Teeling J.L., Felton L.M., Deacon R.M., Cunningham C., Rawlins J.N., Perry V.H. Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav. Immun. 2007, 21:836-850.
150. Teske J.A., Billington C.J., Kotz C.M. Hypocretin/orexin and energy expenditure. Acta Physiol. (Oxf.) 2010, 198:303-312.
151. Teske J.A., Billington C.J., Kotz C.M. Neuropeptidergic mediators of spontaneous physical activity and non-exercise activity thermogenesis. Neuroendocrinology 2008, 87:71-90.
152. Torres-Harding S., Jason L.A. What is fatigue? History and epidemiology. Fatigue as a window to the brain 2005, 3-17. MIT Press, Cambridge. J. DeLuca (Ed.).
153. Van der Zee E.A., Roman V., Ten B.rinke O., Meerlo P. TGFalpha and AVP in the mouse suprachiasmatic nucleus: anatomical relationship and daily profiles. Brain Res. 2005, 1054:159-166.
154. van Kessel K., Moss-Morris R., Willoughby E., Chalder T., Johnson M.H., Robinson E. A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom Med. 2008, 70:205-213.
155. Vestergaard S., Nayfield S.G., Patel K.V., Eldadah B., Cesari M., Ferrucci L., Ceresini G., Guralnik J.M. Fatigue in a representative population of older persons and its association with functional impairment, functional limitation, and disability. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64:76-82.
156. Vosko A.M., Schroeder A., Loh D.H., Colwell C.S. Vasoactive intestinal peptide and the mammalian circadian system. Gen. Comp. Endocrinol. 2007, 152:165-175.
157. Vyazovskiy V.V., Olcese U., Hanlon E.C., Nir Y., Cirelli C., Tononi G. Local sleep in awake rats. Nature 2011, 472:443-447.
158. Vyazovskiy V.V., Tobler I. Theta activity in the waking EEG is a marker of sleep propensity in the rat. Brain Res. 2005, 1050:64-71.
159. Wang X.S. Cancer-related fatigue: clinical science. Cancer Symptom Science: Measurement, Mechanisms, and Management 2011, 110-123. Cambridge University Press, Cambridge. C.S. Cleeland, M.J. Fisch, A.J. Dunn (Eds.).
160. Wang D.V., Tsien J.Z. Conjunctive processing of locomotor signals by the ventral tegmental area neuronal population. PLoS One 2011, 6:e16528.
161. Watanabe A., Shibata S., Watanabe S. Circadian rhythm of spontaneous neuronal activity in the suprachiasmatic nucleus of old hamster in vitro. Brain Res. 1995, 695:237-239.
162. Zedlitz A.M., Rietveld T.C., Geurts A.C., Fasotti L. Cognitive and graded activity training can alleviate persistent fatigue after stroke: a randomized, controlled trial. Stroke 2012, 43:1046-1051.
163. Zhang C., Truong K.K., Zhou Q.Y. Efferent projections of prokineticin 2 expressing neurons in the mouse suprachiasmatic nucleus. PLoS One 2009, 4:e7151.
164. Zou J., Yuan J., Lv S., Tu J. Effects of exercise on behavior and peripheral blood lymphocyte apoptosis in a rat model of chronic fatigue syndrome. J. Huazhong Univ. Sci. Technol. Med. Sci. 2010, 30:258-264.